US › Healthcare

Exicure Inc (XCUR)

US · Healthcare · Biotechnology

$1.54-2.53%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-1.8M

Profit YoY

-160.7%

EPS

$-0.39

EPS estimate

$0.00

Key statistics

Market cap

$10.1M

Forward P/E

0.0

P/B

4.86

Book value

$0.33

EPS (TTM)

$-1.57

52-week high

$9.48

52-week low

$1.43

50-day MA

$2.31

200-day MA

$3.93

Beta

3.66

Analyst view

Analysts rate Exicure Inc a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $2.00.

Shareholding

Insiders

42.59%

Institutions

2.69%

Largest institutional holders

Fund	Stake
The Carlyle Group Inc	0.88%
Geode Capital Management, LLC	0.58%
Vanguard Capital Management, LLC	0.52%
Vanguard Fiduciary Trust Co	0.21%
Northern Trust Corp	0.17%
BlackRock Inc	0.15%
UBS Group AG	0.01%
Tower Research Capital LLC	0.01%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Exicure Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.